THC morpholinylbutyrate: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''THC Morpholinylbutyrate''' is a synthetic | '''THC Morpholinylbutyrate''' is a synthetic derivative of [[tetrahydrocannabinol]] (THC), the principal psychoactive constituent of the [[cannabis]] plant. This compound is of interest in the field of [[pharmacology]] due to its potential therapeutic applications and its unique chemical properties. | ||
== | === Chemical Structure === | ||
THC Morpholinylbutyrate | THC Morpholinylbutyrate is characterized by the addition of a morpholinylbutyrate group to the THC molecule. This modification is designed to alter the pharmacokinetic properties of THC, potentially enhancing its [[bioavailability]] and [[metabolism|metabolic stability]]. The chemical structure of THC Morpholinylbutyrate is depicted in the image to the right. | ||
== | === Pharmacological Properties === | ||
The pharmacological | The pharmacological effects of THC Morpholinylbutyrate are similar to those of natural THC, including [[analgesic]], [[anti-inflammatory]], and [[psychoactive]] effects. However, the synthetic modification may result in differences in potency, duration of action, and side effect profile. Research is ongoing to determine the full spectrum of its pharmacological activity. | ||
== | === Therapeutic Applications === | ||
Potential therapeutic applications of THC Morpholinylbutyrate include the treatment of [[chronic pain]], [[nausea]] and [[vomiting]] associated with [[chemotherapy]], and [[appetite stimulation]] in patients with [[cachexia]]. Its modified structure may offer advantages over natural THC in terms of reduced psychoactivity and improved therapeutic index. | |||
== | === Synthesis === | ||
The | The synthesis of THC Morpholinylbutyrate involves the chemical modification of the THC molecule through the introduction of a morpholinylbutyrate moiety. This process requires expertise in [[organic chemistry]] and is typically conducted in a laboratory setting equipped for the handling of controlled substances. | ||
== | == Related Pages == | ||
* [[ | * [[Tetrahydrocannabinol]] | ||
* [[Cannabis]] | |||
* [[Pharmacology]] | |||
* [[Synthetic cannabinoids]] | * [[Synthetic cannabinoids]] | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Synthetic cannabinoids]] | [[Category:Synthetic cannabinoids]] | ||
<gallery> | |||
File:SP-111_structure.png|SP-111 structure | |||
</gallery> | |||
Latest revision as of 23:49, 24 February 2025
THC Morpholinylbutyrate is a synthetic derivative of tetrahydrocannabinol (THC), the principal psychoactive constituent of the cannabis plant. This compound is of interest in the field of pharmacology due to its potential therapeutic applications and its unique chemical properties.
Chemical Structure[edit]
THC Morpholinylbutyrate is characterized by the addition of a morpholinylbutyrate group to the THC molecule. This modification is designed to alter the pharmacokinetic properties of THC, potentially enhancing its bioavailability and metabolic stability. The chemical structure of THC Morpholinylbutyrate is depicted in the image to the right.
Pharmacological Properties[edit]
The pharmacological effects of THC Morpholinylbutyrate are similar to those of natural THC, including analgesic, anti-inflammatory, and psychoactive effects. However, the synthetic modification may result in differences in potency, duration of action, and side effect profile. Research is ongoing to determine the full spectrum of its pharmacological activity.
Therapeutic Applications[edit]
Potential therapeutic applications of THC Morpholinylbutyrate include the treatment of chronic pain, nausea and vomiting associated with chemotherapy, and appetite stimulation in patients with cachexia. Its modified structure may offer advantages over natural THC in terms of reduced psychoactivity and improved therapeutic index.
Synthesis[edit]
The synthesis of THC Morpholinylbutyrate involves the chemical modification of the THC molecule through the introduction of a morpholinylbutyrate moiety. This process requires expertise in organic chemistry and is typically conducted in a laboratory setting equipped for the handling of controlled substances.
Related Pages[edit]
-
SP-111 structure